New York consumer files antitrust complaint against drugmakers over Bystolic
MLex Summary: Counsel for Angela Maffei filed a proposed class-action complaint accusing AbbVie, Allergan, and Forest Laboratories of unlawfully excluding generic substitutes for the branded blood pressure drug Bystolic. The complaint...To view the full article, register now.
Already a subscriber? Click here to view full article